Wednesday, July 17, 2013

Rafarma Pharmaceuticals, Inc. (RAFA) Introduces Operational Subsidiary’s Board of Directors

Rafarma Pharmaceuticals, producer of generic antibiotics and specialty pharmaceuticals in addition to its own line of proprietary products, today issued a press release announcing its operational subsidiary’s Board of Directors. Comprised of industry veterans, the well-qualified team is presented below:

Nadezhda Brusnitsina, Chairman of the Board – Former director of the MBA program for the Russian Academy of National Economy and State Service, under the President of the Russian Federation, where she was also a Professor in the Department of Project Management. Ms. Brusnitsina has a PhD in Economics and over 13 years’ experience in management.

Irina Shashkova, First Deputy to Director-General – With more than 30 years’ experience in various pharmaceutical enterprises, Ms. Shashkova provides a broad range of skills in the industry. She was awarded a certificate of excellence by the Ministry of Health of Russian Federation for her work in advancing pharmaceutical initiatives in Russia.

Andrey Sinitsin, M.D. – Dr. Sinitsin is a medical professional with over 10 years’ experience in marketing and sales of pharmaceutical products. Mr. Sinitsin has been a key contributor in growing Rafarma, particularly in the procurement of production contracts for the company.

Mikhail Nazarychev – Mr. Nazarychev’s experience and skill set are in investment and commercial banking. Mr. Nazarychev obtained his educational degrees at the Russian Federation Finance Academy where he majored in banking and finance. Mr. Nazarychev has played a key role in the financing of the company’s growth and expansion.

Tatiana Leontieva, J.D. – A graduate of Moscow University in Social law, Ms. Leontieva is a seasoned corporate professional who also has held important government positions for the Russian Federation. Ms. Leontieva was part of the team that initiated and founded ZAO Rafarma. She also holds board positions, including a chairmanship, with industry-related companies.

Hartmut Gerlof – Vice President of Textima, Germany. Mr. Gerlof brings to Rafarma a lengthy history of corporate management of large companies within the industry. Mr. Gerlof’s experience allows him to facilitate relations with the German Science and Manufacturing communities for the expansion of Rafarma’s revenue opportunities in Germany.

Professor Dr. Hartwig Steckel – Dr. Steckel is a licensed pharmacist as well as the Director of the Department of Pharmaceutics and Biopharmaceutics (Institute of Pharmacy) at Christian Albrecht University in Kiel, Germany. Dr. Steckel is also a member of the International Association for Pharmaceutical Technology (APV), the American Association for Pharmaceutical Scientists (AAPS) and the German Pharmaceutical Society (DPhG).

CEO Dave Anderson commented, “We welcome these new members and look forward to working closely with such a diverse and experienced board.”

For more information on Rafarma, visit www.Rafarma.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

No comments: